Events

Transparency, Aggregate Spend & HCP Engagement (8/14-8/16)

August 1st 2025

Pharma Forum (March 23-26, 2025)

December 18th 2024

Pharma USA 2025 (March 18-19, 2025)

December 18th 2024

Life Sciences Accounting & Reporting Congress (March 18-20, 2025)

December 18th 2024

Hub and Specialty Pharmacy Models East (March 18-20, 2025)

December 18th 2024

PAP – Patient Assistance & Access Programs (March 18-20, 2025)

December 18th 2024

Rare Disease Summit (March 18-20, 2025)

December 18th 2024

Speaker Programs Summit (March 3-5, 2025)

December 18th 2024

Clinical Data Disclosure, Transparency and Plain Language Summaries (Feb. 25-26, 2025)

December 18th 2024

Indegene Digital Summit 2024 (October 17-18)

October 3rd 2024

2024 Life Sciences Accounting & Reporting Congress

February 8th 2024

2024 Rare Disease Summit - 3/19-21

February 8th 2024

Pharma Forum EMEA (11/13-11/15)

May 1st 2023

Compliance Congress for Specialty Products (9/19-9/21)

May 1st 2023

Independent Medical Education & Grants Summit (9/19-9/21)

May 1st 2023

Finance & Accounting for Bioscience Companies (9/19-9/20)

May 1st 2023

Health Systems & Pharma Partnering Summit (8/14-8/16)

May 1st 2023

Pharmaceutical Compliance Congress —4/25-4/27

April 25th 2023

Pharma USA 2023 — 3/28-3/29

March 28th 2023

Pharmaceutical Compliance Congress Canada (6/6 - 6/8/23)

January 20th 2023

Drug Pricing Transparency Congress (5/16 - 5/17/23)

January 20th 2023

Medicaid & Government Pricing Congress (5/16 - 5/18/23)

January 20th 2023

Pharmaceutical Compliance Congress (4/25 - 4/27/2023)

January 20th 2023

Rare Disease Innovation & Partnership Summit (3/21 - 3/23/23)

January 20th 2023

PAP – Patient Assistance & Access Programs (3/20 - 3/22/23)

January 20th 2023

Pharma Forum (3/19 - 3/22/23)

January 20th 2023

Life Sciences Accounting & Reporting Congress (3/14 - 3/16/23)

January 20th 2023

Speaker Programs Summit (2/27 - 3/1)

January 20th 2023

Pharma 2023 Europe (4/18 - 4/19)

January 9th 2023

Pharma USA 2023 (3/28 - 3/29)

January 9th 2023

Events

Transparency, Aggregate Spend & HCP Engagement (8/14-8/16)

Pharma Forum (March 23-26, 2025)

Pharma USA 2025 (March 18-19, 2025)

Life Sciences Accounting & Reporting Congress (March 18-20, 2025)

Hub and Specialty Pharmacy Models East (March 18-20, 2025)

PAP – Patient Assistance & Access Programs (March 18-20, 2025)

Rare Disease Summit (March 18-20, 2025)

Speaker Programs Summit (March 3-5, 2025)

Clinical Data Disclosure, Transparency and Plain Language Summaries (Feb. 25-26, 2025)

Indegene Digital Summit 2024 (October 17-18)

2024 Life Sciences Accounting & Reporting Congress

2024 Rare Disease Summit - 3/19-21

Pharma Forum EMEA (11/13-11/15)

Compliance Congress for Specialty Products (9/19-9/21)

Independent Medical Education & Grants Summit (9/19-9/21)

Finance & Accounting for Bioscience Companies (9/19-9/20)

Health Systems & Pharma Partnering Summit (8/14-8/16)

Pharmaceutical Compliance Congress —4/25-4/27

Pharma USA 2023 — 3/28-3/29

Pharmaceutical Compliance Congress Canada (6/6 - 6/8/23)

Drug Pricing Transparency Congress (5/16 - 5/17/23)

Medicaid & Government Pricing Congress (5/16 - 5/18/23)

Pharmaceutical Compliance Congress (4/25 - 4/27/2023)

Rare Disease Innovation & Partnership Summit (3/21 - 3/23/23)

PAP – Patient Assistance & Access Programs (3/20 - 3/22/23)

Pharma Forum (3/19 - 3/22/23)

Life Sciences Accounting & Reporting Congress (3/14 - 3/16/23)

Speaker Programs Summit (2/27 - 3/1)

Pharma 2023 Europe (4/18 - 4/19)

Pharma USA 2023 (3/28 - 3/29)

Trending on PharmExec

Nimbus Therapeutics and Eli Lilly Enter $1.3 Billion License Agreement and Research Collaboration for Oral Obesity Treatments

Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction

Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.

The Real Value Equation: How Humans and AI Create and Destroy Value in Pharma

Parental Control: Why Pharma’s Strongest Asset May Be Its Parent Brand